PHARMA360
DEAD

Serial Number

87597824

Owner

Informa UK Limited

Attorney

Kathryn Starshak

Filing Date

Sep 6, 2017

Add to watchlist:

No watchlists yet
View on USPTO

PHARMA360 Trademark

Serial Number: 87597824

PHARMA360 is a trademark filed by Informa UK Limited on September 6, 2017. The trademark is classified under Class 44 (Medical Services), Class 35 (Advertising & Business). The application is currently no longer active.

Owner Contact Info

Informa UK Limited (69 trademarks)

5 Howick Place
London SW1P1WG , GB

Entity Type: 11

Trademark Details

Filing Date

September 6, 2017

Registration Date

Not Registered

Goods & Services

Compilation of information into computer databases; systemization of information into computer databases; preparation of business reports, namely, data collection and the provision of reports relating thereto; data processing services of computer files for others; demonstration of goods; economic forecasting services; business research and investigations; business enquiries and investigations; online media monitoring services using computer software to automatically monitor internet websites and online publications for customer-specified topics and to capture relevant content on those topics, and providing documentation and analysis of that online content to others for business purposes; arranging newspaper subscriptions for others; providing statistical information for business or commercial purposes; business research; compilation of statistics; subscription services to financial or business publications, and to telephone and Internet services; provision of commercial information and advice to prospective purchasers of goods, including those from such services provided online, from a database, via the internet, or any other communications network; business information services in the nature of analysis, collection, compilation, dissemination, research and updating of business information; providing business information via a web site; business information services in the nature of collection, analysis, compilation, dissemination, research and updating of business information in relation to medicine, pharmaceuticals and the pharmaceutical industry; business information in relation to the medical and pharmaceutical industries; providing business information via a web site in relation to the medical and pharmaceutical industries; compilation of medical reports; information, consultancy and advisory services relating to all the aforesaid services including such services provided on-line or via the Internet

Pharmaceutical consultation; pharmaceutical advice; pharmaceutical advisory services; providing information relating to diagnostic, prophylactic and therapeutic properties of pharmaceuticals; consultancy and information services relating to pharmaceutical products; medical consultation; supply of information in the area of the medicine and pharmaceuticals; pharmaceutical advice in the nature of expert advice relating to pharmaceuticals; pharmaceutical advice in the nature of expert consultancy services in connection with pharmaceuticals; pharmaceutical advice in the nature of expert opinion relating to pharmaceuticals; pharmaceutical advice in the nature of expert reporting services relating to pharmaceuticals; medical services; advisory medical services and the provision of medical information; dentistry services; advisory services and the provision of information relating to dentistry; advisory services and the provision of information relating to health; medical services in the nature of health risk assessment surveys; the provision of information relating to pharmaceuticals; dispensing of pharmaceuticals; veterinary services; preparation of medical reports; issuing of medical reports; medical analysis services for diagnostic and treatment purposes; medical testing services for diagnostic and treatment purposes; surgical treatment services; advisory services and the provision of information relating to surgery, including cosmetic surgery; advisory services and the provision of information relating to cosmetic treatment; hygienic and beauty care for human beings or animals; beauty therapy services; provision of medical and pharmaceutical services; advisory services relating to medical services and pharmaceuticals; consultancy and information services relating to medical products; advisory services relating to pharmaceutical products; consultancy and information services provided via the Internet relating to pharmaceutical products; consultancy and information services relating to biopharmaceutical products; consultancy relating to pharmaceutical and medical products; medical, medicinal and pharmaceutical consultancy; pharmaceutical consultancy; information, consultancy and advisory services relating to all the aforesaid services including such services provided on-line or via the Internet

Filing History

ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPOND
Jun 3, 2021 MAB2
ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE
Jun 2, 2021 ABN2
NOTIFICATION OF SUBSEQUENT FINAL EMAILED
Nov 17, 2020 GNS1
SUBSEQUENT FINAL EMAILED
Nov 17, 2020 GNSF
SUBSEQUENT FINAL REFUSAL WRITTEN
Nov 17, 2020 CFRC
REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
May 11, 2020 RCSC
NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Nov 11, 2019 GNS3
LETTER OF SUSPENSION E-MAILED
Nov 11, 2019 GNSL
SUSPENSION LETTER WRITTEN
Nov 11, 2019 CNSL
TEAS/EMAIL CORRESPONDENCE ENTERED
Oct 16, 2019 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Oct 11, 2019 CRFA
TEAS REQUEST FOR RECONSIDERATION RECEIVED
Oct 11, 2019 ERFR
NOTIFICATION OF FINAL REFUSAL EMAILED
Apr 11, 2019 GNFN
FINAL REFUSAL E-MAILED
Apr 11, 2019 GNFR
FINAL REFUSAL WRITTEN
Apr 11, 2019 CNFR
TEAS/EMAIL CORRESPONDENCE ENTERED
Mar 18, 2019 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Mar 18, 2019 CRFA
TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
Mar 18, 2019 ERSI
NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Feb 28, 2019 GNS3
LETTER OF SUSPENSION E-MAILED
Feb 28, 2019 GNSL
SUSPENSION LETTER WRITTEN
Feb 28, 2019 CNSL
TEAS/EMAIL CORRESPONDENCE ENTERED
Jan 18, 2019 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Jan 17, 2019 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Jan 17, 2019 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Jul 20, 2018 GNRN
NON-FINAL ACTION E-MAILED
Jul 20, 2018 GNRT
NON-FINAL ACTION WRITTEN
Jul 20, 2018 CNRT
TEAS/EMAIL CORRESPONDENCE ENTERED
Jun 21, 2018 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Jun 21, 2018 CRFA
ASSIGNED TO LIE
Jun 18, 2018 ALIE
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Jun 5, 2018 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Dec 18, 2017 GNRN
NON-FINAL ACTION E-MAILED
Dec 18, 2017 GNRT
NON-FINAL ACTION WRITTEN
Dec 18, 2017 CNRT
ASSIGNED TO EXAMINER
Dec 11, 2017 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Sep 12, 2017 NWOS
NEW APPLICATION ENTERED
Sep 9, 2017 NWAP